Epidemiological and clinical characteristics of pregnant women and neonates with COVID-19 in Northwest Mexico멕시코 북서부의 COVID-19에 감염된 임산부 및 신생아의 역학 및 임상 특성Article Published on 2022-09-012022-09-12 Journal: American journal of reproductive immunology (New Y [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] association Bonferroni correction cause Clinical characteristics collected cough COVID-19 COVID-19 symptom death deaths decrease demonstrated determine diagnosed with COVID-19 epidemiological General population IgG Influenza information laboratory parameter less leukocyte mild cases Neonate Neonates no symptom positive pregnant women Pregnant women. rhinorrhea risk factor RT-PCR SARS-CoV-2 virus serological serological test severe COVID-19 severity of COVID-19 Sociodemographic Spread Symptom underlying disease vaccination Vaccine were infected were recorded with COVID-19 [DOI] 10.1111/aji.13583 PMC 바로가기 [Article Type] Article
Highlights of clinical and laboratory parameters among severe COVID-19 patients treated with tocilizumab: a retrospective observational studyArticle Published on 2022-09-012022-11-15 Journal: São Paulo medical journal = Revista paulista de medicina [Category] 진단, 치료기술, [키워드] Admission age analysis analyzed C-reactive protein (CRP Chest Clinical characteristics Comparative conducted Coronavirus disease 2019 COVID-19 COVID-19 patient CRP CRP level CRS Cytokine release syndrome database died disease evaluate ferritin high mortality hospital Hospitalized IL-6 independent risk factor information interleukin-6 laboratory parameter Logistic regression analysis lymphocyte Mortality neutrophil no difference oxygen saturation Patient performed receiving Research retrospective severe COVID-19 patient Signal transduction significantly lower suppresse survival group survived the patient Tocilizumab tocilizumab administration treated Treatment Turkey WBC White blood cell [DOI] 10.1590/1516-3180.2021.0604.R1.23112021 PMC 바로가기
Potential impact of SARS COV-2 infection on the performance of serological assays used to diagnose arboviral diseases아르보바이러스 질병 진단에 사용되는 혈청학적 분석의 성능에 대한 SARS COV-2 감염의 잠재적 영향Article Published on 2022-09-012022-09-12 Journal: Journal of Immunological Methods [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] addition antibody arbovirus Arboviruses Asymptomatic individuals caused Chikungunya China clinical symptom conducted COVID COVID-19 COVID-19 pandemic cross reaction Dengue described diagnose Diagnosis diagnostic disease Diseases evaluate febrile illness increase in Infection infections laboratory parameter less material occur outbreak Potential required Sample SARS CoV-2 SARS CoV-2. SARS-CoV-2 SARS-CoV-2 antibodies SARS-COV-2 infection Serological assay serological cross-reaction Serological testing significantly higher specific antibodies specific IgM Symptoms tested [DOI] 10.1016/j.jim.2022.113312 PMC 바로가기 [Article Type] Article
A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severityObservational Study Published on 2022-08-302022-10-05 Journal: Nature Communications [Category] 바이오마커, 임상, 진단, 치료법, [키워드] age Bilirubin Biomarker Brain C-reactive protein chronic fatigue syndrome Cohort Coronavirus disease 2019 COVID-19 evaluate fatigue ferritin Germany hand healthy hemoglobin Inflammation laboratory parameter long-lasting male median age Mild moderate MOST N-terminal Non-COVID-19 pandemic Pathomechanisms Patient patients peptide Postinfectious prohormone prospective observational cohort prospective observational study severe fatigue severity subset Symptom symptom burden symptom severity syndrome [DOI] 10.1038/s41467-022-32507-6 PMC 바로가기 [Article Type] Observational Study
Reliability of predictive models to support early decision making in the emergency department for patients with confirmed diagnosis of COVID-19: the Pescara Covid Hospital scoreCOVID-19 진단이 확인된 환자의 응급실에서 조기 의사 결정을 지원하는 예측 모델의 신뢰성: Pescara Covid Hospital 점수Article Published on 2022-08-192022-09-11 Journal: BMC health services research [Category] 변종, [키워드] Abruzzo Accuracy Admission age and gender Algorithm Alpha build calibrated can be used carried Characteristics clinical decision collecting data conditions COVID-19 D-dimer death decision Decision making diabete diabetes diagnosed with COVID-19 Diagnosis disease distribution emergency department heterogeneous higher risk hospital hospital management hospitalisation identify independent predictor independent predictors initial intensive care Italy laboratory parameter Laboratory parameters Lactate lactate dehydrogenase Logistic regression monocyte other variant other variants outcome oxygen oxygen support pandemic parameter Patient patients with COVID-19 prediction Prediction score Predictive model predictive models predictor procalcitonin Prognosis renal renal disease Retrospective study risk Risk scores risk stratification saturation significantly Support Survival. threshold validation variants of concern virus were used [DOI] 10.1186/s12913-022-08421-4 PMC 바로가기 [Article Type] Article
Comparison of Laboratory and Hemodynamic Time Series Data Across Original, Alpha, and Delta Variants in Patients With Multisystem Inflammatory Syndrome in ChildrenArticle Published on 2022-08-012022-11-16 Journal: Pediatric critical care medicine : a journal of th [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome all subject Alpha variant assist children Cohort cohort study Continuous coronavirus Delta delta variant entire cohort evaluated extracorporeal membrane oxygenation had more hemodynamic hospital Hospitalization ICU Infection Inflammatory INR Laboratory laboratory parameter Laboratory results LOS male measurement mechanical ventilation median age median value medication MIS-C Modification Mortality occurred original outcome parameter Patient Potassium Prothrombin time Sery severity sodium Symptom syndrome Tachycardia time Treatment protocol variant variants variants of concern ventricular WBCs [DOI] 10.1097/PCC.0000000000002976 PMC 바로가기
Independent predictors of in-hospital mortality and the need for intensive care in hospitalized non-critical COVID-19 patients: a prospective cohort studyObservational Study Published on 2022-08-012022-10-04 Journal: Internal and Emergency Medicine [Category] COVID19(2023년), SARS, 임상, [키워드] active cancer Admission albumin albumin level analysis baseline blood test Blood urea nitrogen build Care Characteristics classical clinical feature condition confidence interval coronavirus COVID-19 death demographic data demographics died evaluate Factor Features Hospitalized hospitalized patient ICU ICU care in-hospital mortality independent independent predictors infected with SARS-CoV-2 intensive care intensive care unit laboratory parameter Male sex Older age outcome Pandemics Patient performed predict Predictive predictor Probability prospective cohort study receiver recruited risk ROC SARS-CoV-2 significant variables single-center study sodium Sodium. Stratification stratified tested the patient underlying disease urea [DOI] 10.1007/s11739-022-02962-6 PMC 바로가기 [Article Type] Observational Study
Clinical laboratory parameters and comorbidities associated with severity of coronavirus disease 2019 (COVID-19) in Kurdistan Region of IraqResearch article Published on 2022-08-012022-10-05 Journal: Practical Laboratory Medicine [Category] 바이오마커, 임상, 진단, [키워드] age Biological biological parameters blood sample blood sugar C-reactive protein (CRP CBC Characteristics characterized Clinical course Clinical data clinical laboratory Comorbidities Comorbidity complete blood count conducted coronavirus disease COVID-19 COVID-19 severity CRP D-dimer Diabetes Mellitus diagnosed with COVID-19 disease Disease progression disease severity elevated erythrocyte sedimentation rate ESR facilitate female females groups include investigated Iraq Kurdistan laboratory parameter Laboratory parameters laboratory result lymphocyte male marker Mild moderate MONITOR Mortality MOST opposite pandemic coronavirus parameter Patient prognostic progression RBC recognize Region relative Result risk factor SARS-CoV-2 Serum ferritin Severe case severe symptoms severity severity of COVID-19 significantly SpO2 Spread Symptom Symptoms the disease WBC with COVID-19 [DOI] 10.1016/j.plabm.2022.e00294 [Article Type] Research article
Fatigue In Covid-19 Survivors: The Potential Impact Of A Nutritional Supplement On Muscle Strength And FunctionResearch article Published on 2022-08-012022-10-05 Journal: Clinical nutrition ESPEN [Category] 바이오마커, [키워드] acute COVID-19 affected aging All participant amino acids Analysis analyzed blood biochemistry Body body composition Chair stand test COVID-19 enrolled evaluate evaluated fatigue ferritin level ferritin levels function hand hand grip strength Health Health status Hospitalized Impact invasive ventilation laboratory parameter Long COVID long-lasting low-flow oxygen supplementation Minerals muscle Muscle function Muscle strength NIV Noninvasive ventilation not significant Older parameters participant Patient performed physical Potential Quality of life reduced reduction repetition Result Rome strength strength test survivor Survivors Tolerance Visual Analogue Scale vitamins was obtained [DOI] 10.1016/j.clnesp.2022.08.029 [Article Type] Research article
Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessmentClinical Trial Published on 2022-07-282022-10-05 Journal: Stem Cell Research & Therapy [Category] COVID19(2023년), SARS, 임상, [키워드] acute respiratory distress acute respiratory distress syndrome (ARDS) administration adverse event Allogeneic Anti-inflammatory ARDS baseline cause caused Cell Cell therapy clinical Clinical sign clinical trial control group coronavirus COVID-19 COVID-19 pandemic death in COVID-19 demonstrated distress dose Efficacy enrolled evaluate evaluated feasible Health Hospitalization Human immunomodulatory injection intensive care intravenous Intravenous injection intravenously laboratory parameter Laboratory test mesenchymal stem cell morbidity and mortality not significantly different oxygen saturation participant Patient patients patients with ARDS patients with COVID-19 Phase I PL-MSC PL-MSCs Placenta mesenchymal stem cells (PL-MSC). protocol regenerative registry repeated Safe Safety assessment safety profile serum single dose standard treatment stem cell subject syndrome Treatment treatment group two group [DOI] 10.1186/s13287-022-02953-6 PMC 바로가기 [Article Type] Clinical Trial